{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T10:29:31Z","timestamp":1763202571029,"version":"3.37.3"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007776","name":"deanship of academic research, the university of jordan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007776","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10822-021-00435-0","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:04:01Z","timestamp":1642723441000},"page":"39-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exploiting activity cliffs for building pharmacophore models and comparison with other pharmacophore generation methods: sphingosine kinase 1 as case study"],"prefix":"10.1007","volume":"36","author":[{"given":"Lubabah A.","family":"Mousa","sequence":"first","affiliation":[]},{"given":"Ma\u2019mon M.","family":"Hatmal","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4453-072X","authenticated-orcid":false,"given":"Mutasem","family":"Taha","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"435_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-020-00315-z","author":"D Stumpfe","year":"2020","unstructured":"Stumpfe D, Hu H, Bajorath J (2020) Advances in exploring activity cliffs. J Comput Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-020-00315-z","journal-title":"J Comput Aided Mol Des"},{"key":"435_CR2","doi-asserted-by":"publisher","DOI":"10.1021\/ci300306a","author":"K Heikamp","year":"2012","unstructured":"Heikamp K, Hu X, Yan A, Bajorath J (2012) Prediction of activity cliffs using support vector machines. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci300306a","journal-title":"J Chem Inf Model"},{"key":"435_CR3","doi-asserted-by":"publisher","DOI":"10.1021\/ci3000503","author":"V Namasivayam","year":"2012","unstructured":"Namasivayam V, Bajorath J (2012) Searching for coordinated activity cliffs using particle swarm optimization. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci3000503","journal-title":"J Chem Inf Model"},{"key":"435_CR4","doi-asserted-by":"publisher","DOI":"10.1021\/ci400597d","author":"V Namasivayam","year":"2013","unstructured":"Namasivayam V, Iyer P, Bajorath J (2013) Prediction of individual compounds forming activity cliffs using emerging chemical patterns. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci400597d","journal-title":"J Chem Inf Model"},{"key":"435_CR5","doi-asserted-by":"publisher","DOI":"10.1021\/ci300047k","author":"R Guha","year":"2012","unstructured":"Guha R (2012) Exploring uncharted territories: predicting activity cliffs in structure-activity landscapes. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci300047k","journal-title":"J Chem Inf Model"},{"key":"435_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201100179","author":"B Seebeck","year":"2011","unstructured":"Seebeck B, Wagener M, Rarey M (2011) From activity cliffs to target-specific scoring models and pharmacophore hypotheses. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.201100179","journal-title":"ChemMedChem"},{"key":"435_CR7","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.2-199.v1","author":"Y Hu","year":"2013","unstructured":"Hu Y, Bajorath J, Stumpfe D (2013) Advancing the activity cliff concept. F1000Research. https:\/\/doi.org\/10.12688\/f1000research.2-199.v1","journal-title":"F1000Research"},{"key":"435_CR8","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00812","author":"E R\u00fchmann","year":"2015","unstructured":"R\u00fchmann E, Betz M, Heine A, Klebe G (2015) Fragment binding can be either more enthalpy-driven or entropy-driven: crystal structures and residual hydration patterns suggest why. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00812","journal-title":"J Med Chem"},{"key":"435_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200206","author":"A Biela","year":"2012","unstructured":"Biela A, Betz M, Heine A, Klebe G (2012) Water makes the difference: rearrangement of water solvation layer triggers non-additivity of functional group contributions in protein-ligand binding. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.201200206","journal-title":"ChemMedChem"},{"key":"435_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201400013","author":"SG Krimmer","year":"2014","unstructured":"Krimmer SG, Betz M, Heine A, Klebe G (2014) Methyl, ethyl, propyl, butyl: futile but not for water, as the correlation of structure and thermodynamic signature shows in a congeneric series of thermolysin inhibitors. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.201400013","journal-title":"ChemMedChem"},{"key":"435_CR11","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990604","author":"M Reddy","year":"2014","unstructured":"Reddy M, Reddy C, Rathore R, Erion M, Aparoy P, Reddy R et al (2014) Free energy calculations to estimate ligand-binding affinities in structure-based drug design. Curr Pharm Des. https:\/\/doi.org\/10.2174\/13816128113199990604","journal-title":"Curr Pharm Des"},{"key":"435_CR12","doi-asserted-by":"publisher","DOI":"10.1021\/ct300899n","author":"P Gkeka","year":"2013","unstructured":"Gkeka P, Eleftheratos S, Kolocouris A, Cournia Z (2013) Free energy calculations reveal the origin of binding preference for aminoadamantane blockers of influenza A\/M2TM pore. J Chem Theory Comput. https:\/\/doi.org\/10.1021\/ct300899n","journal-title":"J Chem Theory Comput"},{"key":"435_CR13","doi-asserted-by":"publisher","DOI":"10.1021\/ci4004199","author":"CD Christ","year":"2014","unstructured":"Christ CD, Fox T (2014) Accuracy assessment and automation of free energy calculations for drug design. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci4004199","journal-title":"J Chem Inf Model"},{"key":"435_CR14","doi-asserted-by":"publisher","DOI":"10.1021\/ja512751q","author":"L Wang","year":"2015","unstructured":"Wang L, Wu Y, Deng Y, Kim B, Pierce L, Krilov G et al (2015) Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J Am Chem Soc. https:\/\/doi.org\/10.1021\/ja512751q","journal-title":"J Am Chem Soc"},{"key":"435_CR15","doi-asserted-by":"publisher","unstructured":"Medina-Franco JL, M\u00e9ndez-Lucio O, Martinez-Mayorga K (2014). The interplay between molecular modeling and chemoinformatics to characterize protein-ligand and protein-protein interactions landscapes for drug discovery. In: Advances in protein chemistry and structural biology. https:\/\/doi.org\/10.1016\/bs.apcsb.2014.06.001","DOI":"10.1016\/bs.apcsb.2014.06.001"},{"key":"435_CR16","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.8b01290","author":"L P\u00e9rez-Benito","year":"2019","unstructured":"P\u00e9rez-Benito L, Casajuana-Martin N, Jim\u00e9nez-Ros\u00e9s M, Van Vlijmen H, Tresadern G (2019) Predicting activity cliffs with free-energy perturbation. J Chem Theory Comput. https:\/\/doi.org\/10.1021\/acs.jctc.8b01290","journal-title":"J Chem Theory Comput"},{"key":"435_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2020.107615","author":"S Daoud","year":"2020","unstructured":"Daoud S, Taha MO (2020) Pharmacophore modeling of JAK1: a target infested with activity-cliffs. J Mol Graph Model. https:\/\/doi.org\/10.1016\/j.jmgm.2020.107615","journal-title":"J Mol Graph Model"},{"key":"435_CR18","doi-asserted-by":"publisher","DOI":"10.1021\/ci060117s","author":"GM Maggiora","year":"2006","unstructured":"Maggiora GM (2006) On outliers and activity cliffs\u2014why QSAR often disappoints. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci060117s","journal-title":"J Chem Inf Model"},{"key":"435_CR19","doi-asserted-by":"publisher","DOI":"10.1021\/jm201706b","author":"D Stumpfe","year":"2012","unstructured":"Stumpfe D, Bajorath J (2012) Exploring activity cliffs in medicinal chemistry. J Med Chem. https:\/\/doi.org\/10.1021\/jm201706b","journal-title":"J Med Chem"},{"key":"435_CR20","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2012.679616","author":"J Bajorath","year":"2012","unstructured":"Bajorath J (2012) Modeling of activity landscapes for drug discovery. Exp Opin Drug Disc. https:\/\/doi.org\/10.1517\/17460441.2012.679616","journal-title":"Exp Opin Drug Disc"},{"key":"435_CR21","doi-asserted-by":"publisher","DOI":"10.1021\/jm0705713","author":"L Peltason","year":"2007","unstructured":"Peltason L, Bajorath J (2007) SAR index: quantifying the nature of structure-activity relationships. J Med Chem. https:\/\/doi.org\/10.1021\/jm0705713","journal-title":"J Med Chem"},{"key":"435_CR22","doi-asserted-by":"publisher","DOI":"10.1021\/ci7004093","author":"R Guha","year":"2008","unstructured":"Guha R, Van Drie JH (2008) Structure\u2014activity landscape index: Identifying and quantifying activity cliffs. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci7004093","journal-title":"J Chem Inf Model"},{"key":"435_CR23","doi-asserted-by":"publisher","DOI":"10.1021\/ci2002473","author":"M Vogt","year":"2011","unstructured":"Vogt M, Huang Y, Bajorath J (2011) From activity cliffs to activity ridges: Informative data structures for SAR analysis. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci2002473","journal-title":"J Chem Inf Model"},{"key":"435_CR24","doi-asserted-by":"publisher","DOI":"10.1021\/ci300274c","author":"Y Hu","year":"2012","unstructured":"Hu Y, Bajorath J (2012) Extending the activity cliff concept: Structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci300274c"},{"key":"435_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.01.014","author":"G Klebe","year":"2019","unstructured":"Klebe G (2019) Broad-scale analysis of thermodynamic signatures in medicinal chemistry: are enthalpy-favored binders the better development option? Drug Discov Today. https:\/\/doi.org\/10.1016\/j.drudis.2019.01.014","journal-title":"Drug Discov Today"},{"key":"435_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02258-w","author":"M Amaral","year":"2017","unstructured":"Amaral M, Kokh DB, Bomke J, Wegener A, Buchstaller HP, Eggenweiler HM et al (2017) Protein conformational flexibility modulates kinetics and thermodynamics of drug binding. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-017-02258-w","journal-title":"Nat Commun"},{"key":"435_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2011.06.001","author":"C Koch","year":"2011","unstructured":"Koch C, Heine A, Klebe G (2011) Ligand-induced fit affects binding modes and provokes changes in crystal packing of aldose reductase. Biochim Biophys Acta Gen Subj. https:\/\/doi.org\/10.1016\/j.bbagen.2011.06.001","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"435_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2007.08.063","author":"H Steuber","year":"2007","unstructured":"Steuber H, Czodrowski P, Sotriffer CA, Klebe G (2007) Tracing changes in protonation: a prerequisite to factorize thermodynamic data of inhibitor binding to aldose reductase. J Mol Biol. https:\/\/doi.org\/10.1016\/j.jmb.2007.08.063","journal-title":"J Mol Biol"},{"key":"435_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2006.12.004","author":"H Steuber","year":"2007","unstructured":"Steuber H, Heine A, Klebe G (2007) Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution. J Mol Biol. https:\/\/doi.org\/10.1016\/j.jmb.2006.12.004","journal-title":"J Mol Biol"},{"key":"435_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175723","author":"FR Ehrmann","year":"2017","unstructured":"Ehrmann FR, Stojko J, Metz A, Debaene F, Barandun LJ, Heine A et al (2017) Soaking suggests \u201calternative facts\u201d: Only cocrystallization discloses major ligand-induced interface rearrangements of a homodimeric tRNA-binding protein indicating a novel mode-of-inhibition. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0175723","journal-title":"PLoS ONE"},{"key":"435_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201600509","author":"A Zubrien\u0117","year":"2016","unstructured":"Zubrien\u0117 A, Smirnov A, Dudutien\u0117 V, Timm DD, Matulien\u0117 J, Michailovien\u0117 V et al (2016) Intrinsic thermodynamics and structures of 2,4- and 3,4-substituted fluorinated benzenesulfonamides binding to carbonic anhydrases. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.201600509","journal-title":"ChemMedChem"},{"key":"435_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114106","author":"M Kisonaite","year":"2014","unstructured":"Kisonaite M, Zubriene A, Capkauskaite E, Smirnov A, Smirnoviene J, Kairys V et al (2014) Intrinsic thermodynamics and structure correlation of benzenesulfonamides with a pyrimidine moiety binding to carbonic anhydrases I, II, VII, XII, and XIII. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0114106","journal-title":"PLoS ONE"},{"key":"435_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.05.068","author":"KH DuBay","year":"2009","unstructured":"DuBay KH, Geissler PL (2009) Calculation of proteins\u2019 total side-chain torsional entropy and its influence on protein-ligand interactions. J Mol Biol. https:\/\/doi.org\/10.1016\/j.jmb.2009.05.068","journal-title":"J Mol Biol"},{"key":"435_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0020168","author":"J Zhang","year":"2006","unstructured":"Zhang J, Liu JS (2006) On side-chain conformational entropy of proteins. PLoS Comput Biol. https:\/\/doi.org\/10.1371\/journal.pcbi.0020168","journal-title":"PLoS Comput Biol"},{"key":"435_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5560041101","author":"AJ Doig","year":"1995","unstructured":"Doig AJ, Sternberg MJE (1995) Side-chain conformational entropy in protein folding. Protein Sci. https:\/\/doi.org\/10.1002\/pro.5560041101","journal-title":"Protein Sci"},{"key":"435_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8653","author":"N Plattner","year":"2015","unstructured":"Plattner N, No\u00e9 F (2015) Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms8653","journal-title":"Nat Commun"},{"key":"435_CR37","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.7b00708","author":"MM Hatmal","year":"2018","unstructured":"Hatmal MM, Taha MO (2018) Combining stochastic deformation\/relaxation and intermolecular contacts analysis for extracting pharmacophores from ligand-receptor complexes. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.7b00708","journal-title":"J Chem Inf Model"},{"key":"435_CR38","doi-asserted-by":"publisher","DOI":"10.1021\/jm900817u","author":"AR Leach","year":"2010","unstructured":"Leach AR, Gillet VJ, Lewis RA, Taylor R (2010) Three-dimensional pharmacophore methods in drug discovery. J Med Chem. https:\/\/doi.org\/10.1021\/jm900817u","journal-title":"J Med Chem"},{"key":"435_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2019.05.015","author":"GO Tuffaha","year":"2019","unstructured":"Tuffaha GO, Hatmal MM, Taha MO (2019) Discovery of new JNK3 inhibitory chemotypes via QSAR-Guided selection of docking-based pharmacophores and comparison with other structure-based pharmacophore modeling methods. J Mol Gr Model. https:\/\/doi.org\/10.1016\/j.jmgm.2019.05.015","journal-title":"J Mol Gr Model"},{"key":"435_CR40","doi-asserted-by":"publisher","DOI":"10.1124\/pr.112.007336","author":"G Sliwoski","year":"2014","unstructured":"Sliwoski G, Kothiwale S, Meiler J, Lowe EW (2014) Computational methods in drug discovery. Pharmacol Rev. https:\/\/doi.org\/10.1124\/pr.112.007336","journal-title":"Pharmacol Rev"},{"key":"435_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2018.02.001","author":"MA Al-Sha\u2019er","year":"2018","unstructured":"Al-Sha\u2019er MA, Taha MO (2018) Ligand-based modeling of Akt3 lead to potent dual Akt1\/Akt3 inhibitor. J Mol Gr Model. https:\/\/doi.org\/10.1016\/j.jmgm.2018.02.001","journal-title":"J Mol Gr Model"},{"key":"435_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/183918","author":"E Paquet","year":"2015","unstructured":"Paquet E, Viktor HL (2015) Molecular dynamics, Monte Carlo simulations, and langevin dynamics: a computational review. Biomed Res Int. https:\/\/doi.org\/10.1155\/2015\/183918","journal-title":"Biomed Res Int"},{"key":"435_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.96","author":"B Ogretmen","year":"2017","unstructured":"Ogretmen B (2017) Sphingolipid metabolism in cancer signaling and therapy. Nat Rev Cancer. https:\/\/doi.org\/10.1038\/nrc.2017.96","journal-title":"Nat Rev Cancer"},{"key":"435_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2011.09.003","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. https:\/\/doi.org\/10.1016\/j.tcb.2011.09.003","journal-title":"Trends Cell Biol"},{"key":"435_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2018.08.015","author":"MJ Pulkoski-Gross","year":"2018","unstructured":"Pulkoski-Gross MJ, Obeid LM (2018) Molecular mechanisms of regulation of sphingosine kinase 1. Biochimica et Biophysica Acta Mol Cell Biol Lipids. https:\/\/doi.org\/10.1016\/j.bbalip.2018.08.015","journal-title":"Biochimica et Biophysica Acta Mol Cell Biol Lipids"},{"key":"435_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25051130","author":"K Boche\u0144ska","year":"2020","unstructured":"Boche\u0144ska K, Gabig-Cimi\u0144ska M (2020) Unbalanced sphingolipid metabolism and its implications for the pathogenesis of psoriasis. Molecules. https:\/\/doi.org\/10.3390\/molecules25051130","journal-title":"Molecules"},{"key":"435_CR47","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20190091","author":"A Gomez-Larrauri","year":"2020","unstructured":"Gomez-Larrauri A, Presa N, Dominguez-Herrera A, Ouro A, Trueba M, Gomez-Munoz A (2020) Role of bioactive sphingolipids in physiology and pathology. Essays Biochem. https:\/\/doi.org\/10.1042\/EBC20190091","journal-title":"Essays Biochem"},{"key":"435_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00833","author":"A Kroll","year":"2020","unstructured":"Kroll A, Cho HE, Kang MH (2020) Antineoplastic agents targeting sphingolipid pathways. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.00833","journal-title":"Front Oncol"},{"key":"435_CR49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.X120.012838","author":"S Spiegel","year":"2020","unstructured":"Spiegel S (2020) Sphingosine-1-phosphate: from insipid lipid to a key regulator. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.X120.012838","journal-title":"J Biol Chem"},{"key":"435_CR50","doi-asserted-by":"publisher","DOI":"10.2174\/1573409916666200611122736","author":"MA Al-Sha\u2019er","year":"2020","unstructured":"Al-Sha\u2019er MA, Taha MO (2020) Elaboration of novel TTK1 inhibitory leads via QSAR-guided selection of crystallographic pharmacophores followed by in vitro assay. Curr Comput Aided Drug Des. https:\/\/doi.org\/10.2174\/1573409916666200611122736","journal-title":"Curr Comput Aided Drug Des"},{"key":"435_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2016.1218485","author":"MA Al-Sha\u2019er","year":"2016","unstructured":"Al-Sha\u2019er MA, Mansi I, Khanfar M, Abudayyh A (2016) Discovery of new heat shock protein 90 inhibitors using virtual co-crystallized pharmacophore generation. J Enzyme Inhib Med Chem. https:\/\/doi.org\/10.1080\/14756366.2016.1218485","journal-title":"J Enzyme Inhib Med Chem"},{"key":"435_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2014.12.003","author":"MO Taha","year":"2015","unstructured":"Taha MO, Habash M, Hatmal MM, Abdelazeem AH, Qandil A (2015) Ligand-based modeling followed by in vitro bioassay yielded new potent glucokinase activators. J Mol Gr Model. https:\/\/doi.org\/10.1016\/j.jmgm.2014.12.003","journal-title":"J Mol Gr Model"},{"key":"435_CR53","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2016-0056","author":"SJ Alabed","year":"2016","unstructured":"Alabed SJ, Khanfar M, Taha MO (2016) Computer-aided discovery of new FGFR-1 inhibitors followed by in vitro validation. Future Med Chem. https:\/\/doi.org\/10.4155\/fmc-2016-0056","journal-title":"Future Med Chem"},{"key":"435_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2017.10.003","author":"RA Al-Aqtash","year":"2017","unstructured":"Al-Aqtash RA, Zihlif MA, Hammad H, Nassar ZD, Al MJ, Taha MO (2017) Ligand-based computational modelling of platelet-derived growth factor beta receptor leading to new angiogenesis inhibitory leads. Comput Biol Chem. https:\/\/doi.org\/10.1016\/j.compbiolchem.2017.10.003","journal-title":"Comput Biol Chem"},{"key":"435_CR55","doi-asserted-by":"publisher","DOI":"10.2174\/0929867013372481","author":"Y Kurogi","year":"2012","unstructured":"Kurogi Y, Guner O (2012) Pharmacophore modeling and three-dimensional database searching for drug design using catalyst. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867013372481","journal-title":"Curr Med Chem"},{"key":"435_CR56","doi-asserted-by":"publisher","DOI":"10.1021\/jm800718k","author":"MO Taha","year":"2008","unstructured":"Taha MO, Dahabiyeh LA, Bustanji Y, Zalloum H, Saleh S (2008) Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors. J Med Chem. https:\/\/doi.org\/10.1021\/jm800718k","journal-title":"J Med Chem"},{"key":"435_CR57","doi-asserted-by":"publisher","DOI":"10.1021\/ci8003682","author":"AM Abuhammad","year":"2009","unstructured":"Abuhammad AM, Taha MO (2009) Pharmacophore modeling, quantitative structure\u2014activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci8003682","journal-title":"J Chem Inf Model"},{"key":"435_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.07.056","author":"MO Taha","year":"2014","unstructured":"Taha MO, Al-Sha\u2019Er MA, Khanfar MA, Al-Nadaf AH (2014) Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3K\u03b3) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.056","journal-title":"Eur J Med Chem"},{"key":"435_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-014-0966-4","author":"M Habash","year":"2014","unstructured":"Habash M, Abdelazeem AH, Taha MO (2014) Elaborate ligand-based modeling reveals new human neutrophil elastase inhibitors. Med Chem Res. https:\/\/doi.org\/10.1007\/s00044-014-0966-4","journal-title":"Med Chem Res"},{"key":"435_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2009.12.070","author":"R Abu Khalaf","year":"2010","unstructured":"Abu Khalaf R, Abu Sheikha G, Bustanji Y, Taha MO (2010) Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration. Eur J Med Chem. https:\/\/doi.org\/10.1016\/j.ejmech.2009.12.070","journal-title":"Eur J Med Chem"},{"key":"435_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-013-9699-6","author":"S Abuhamdah","year":"2013","unstructured":"Abuhamdah S, Habash M, Taha MO (2013) Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors. J Comput Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-013-9699-6","journal-title":"J Comput Aided Mol Des"},{"key":"435_CR62","doi-asserted-by":"publisher","DOI":"10.1021\/ci0497531","author":"J Kirchmair","year":"2005","unstructured":"Kirchmair J, Laggner C, Wolber G, Langer T (2005) Comparative analysis of protein-bound ligand conformations with respect to catalyst\u2019s conformational space subsampling algorithms. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci0497531","journal-title":"J Chem Inf Model"},{"key":"435_CR63","doi-asserted-by":"publisher","DOI":"10.1021\/ci700136x","author":"J Li","year":"2007","unstructured":"Li J, Ehlers T, Sutter J, Varma-O\u2019Brien S, Kirchmair J (2007) CAESAR: a new conformer generation algorithm based on recursive buildup and local rotational symmetry consideration. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci700136x","journal-title":"J Chem Inf Model"},{"key":"435_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21367","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe K, Hatcher E, Acharya C, Kundu S, Zhong S, Shim J et al (2010) CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem. https:\/\/doi.org\/10.1002\/jcc.21367","journal-title":"J Comput Chem"},{"key":"435_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2019.01.011","author":"RF Abutayeh","year":"2019","unstructured":"Abutayeh RF, Taha MO (2019) Discovery of novel Flt3 inhibitory chemotypes through extensive ligand-based and new structure-based pharmacophore modelling methods. J Mol Gr Model. https:\/\/doi.org\/10.1016\/j.jmgm.2019.01.011","journal-title":"J Mol Gr Model"},{"key":"435_CR66","doi-asserted-by":"publisher","unstructured":"Poptodorov K, Luu T, Hoffmann RD (2006) Pharmacophore model generation software tools. In: Pharmacophores and pharmacophore searches. https:\/\/doi.org\/10.1002\/3527609164.ch2","DOI":"10.1002\/3527609164.ch2"},{"key":"435_CR67","doi-asserted-by":"publisher","DOI":"10.2174\/0929867043364036","author":"O Guner","year":"2004","unstructured":"Guner O, Clement O, Kurogi Y (2004) Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867043364036","journal-title":"Curr Med Chem"},{"key":"435_CR68","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-011-9509-y","author":"R Shahin","year":"2012","unstructured":"Shahin R, AlQtaishat S, Taha MO (2012) Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors. J Comput Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-011-9509-y","journal-title":"J Comput Aided Mol Des"},{"key":"435_CR69","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/921863","author":"A Pandey","year":"2014","unstructured":"Pandey A, Paliwal SK, Paliwal SK (2014) Chemical feature-based molecular modeling of urotensin-II receptor antagonists: generation of predictive pharmacophore model for early drug discovery. J Chem. https:\/\/doi.org\/10.1155\/2014\/921863","journal-title":"J Chem"},{"key":"435_CR70","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1980.10477512","author":"D Basu","year":"1980","unstructured":"Basu D (1980) Randomization analysis of experimental data: the fisher randomization test. J Am Stat Assoc. https:\/\/doi.org\/10.1080\/01621459.1980.10477512","journal-title":"J Am Stat Assoc"},{"key":"435_CR71","doi-asserted-by":"publisher","unstructured":"Taha MO (2012) Mixing pharmacophore modeling and classical QSAR analysis as powerful tool for lead discovery. In: Virtual screening. https:\/\/doi.org\/10.5772\/20993","DOI":"10.5772\/20993"},{"key":"435_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2013.02.009","author":"MA Khanfar","year":"2013","unstructured":"Khanfar MA, AbuKhader MM, Alqtaishat S, Taha MO (2013) Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone. J Chem Inf Model. https:\/\/doi.org\/10.1016\/j.jmgm.2013.02.009","journal-title":"J Chem Inf Model"},{"key":"435_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/jmr.2623","author":"MA Khanfar","year":"2017","unstructured":"Khanfar MA, Taha MO (2017) Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors. J Mol Recognit. https:\/\/doi.org\/10.1002\/jmr.2623","journal-title":"J Mol Recognit"},{"key":"435_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2006.08.008","author":"MO Taha","year":"2007","unstructured":"Taha MO, Bustanji Y, Al-Bakri AG, Yousef AM, Zalloum WA, Al-Masri IM et al (2007) Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening. J Mol Gr Model. https:\/\/doi.org\/10.1016\/j.jmgm.2006.08.008","journal-title":"J Mol Gr Model"},{"key":"435_CR75","doi-asserted-by":"publisher","DOI":"10.1021\/jm2001053","author":"AJ Kennedy","year":"2011","unstructured":"Kennedy AJ, Mathews TP, Kharel Y, Field SD, Moyer ML, East JE et al (2011) Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. J Med Chem. https:\/\/doi.org\/10.1021\/jm2001053","journal-title":"J Med Chem"},{"key":"435_CR76","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5b00304","author":"MD Congdon","year":"2016","unstructured":"Congdon MD, Kharel Y, Brown AM, Lewis SN, Bevan DR, Lynch KR et al (2016) Structure-activity relationship studies and molecular modeling of naphthalene-based sphingosine kinase 2 inhibitors. ACS Med Chem Lett. https:\/\/doi.org\/10.1021\/acsmedchemlett.5b00304","journal-title":"ACS Med Chem Lett"},{"key":"435_CR77","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.6b00002","author":"JD Houck","year":"2016","unstructured":"Houck JD, Dawson TK, Kennedy AJ, Kharel Y, Naimon ND, Field SD et al (2016) Structural requirements and docking analysis of amidine-based sphingosine kinase 1 inhibitors containing oxadiazoles. ACS Med Chem Lett. https:\/\/doi.org\/10.1021\/acsmedchemlett.6b00002","journal-title":"ACS Med Chem Lett"},{"key":"435_CR78","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b01439","author":"L Aurelio","year":"2016","unstructured":"Aurelio L, Scullino CV, Pitman MR, Sexton A, Oliver V, Davies L et al (2016) From sphingosine kinase to dihydroceramide desaturase: a structure-activity relationship (SAR) study of the enzyme inhibitory and anticancer activity of 4-((4-(4-chlorophenyl)thiazol-2-yl)amino)phenol (SKI-II). J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01439","journal-title":"J Med Chem"},{"key":"435_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2016.05.047","author":"M Xi","year":"2016","unstructured":"Xi M, Ge J, Wang X, Sun C, Liu T, Fang L et al (2016) Development of hydroxy-based sphingosine kinase inhibitors and anti-inflammation in dextran sodium sulfate induced colitis in mice. Bioorgan Med Chem. https:\/\/doi.org\/10.1016\/j.bmc.2016.05.047","journal-title":"Bioorgan Med Chem"},{"key":"435_CR80","doi-asserted-by":"publisher","DOI":"10.1021\/jm4011687","author":"D Plano","year":"2014","unstructured":"Plano D, Amin S, Sharma AK (2014) Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors. J Med Chem. https:\/\/doi.org\/10.1021\/jm4011687","journal-title":"J Med Chem"},{"key":"435_CR81","doi-asserted-by":"publisher","DOI":"10.1021\/jm501760d","author":"NN Patwardhan","year":"2015","unstructured":"Patwardhan NN, Morris EA, Kharel Y, Raje MR, Gao M, Tomsig JL et al (2015) Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors. J Med Chem. https:\/\/doi.org\/10.1021\/jm501760d","journal-title":"J Med Chem"},{"key":"435_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.10.005","author":"JA Hengst","year":"2010","unstructured":"Hengst JA, Wang X, Sk UH, Sharma AK, Amin S, Yun JK (2010) Development of a sphingosine kinase 1 specific small-molecule inhibitor. Bioorgan Med Chem Lett. https:\/\/doi.org\/10.1016\/j.bmcl.2010.10.005","journal-title":"Bioorgan Med Chem Lett"},{"key":"435_CR83","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00233","author":"ES Childress","year":"2017","unstructured":"Childress ES, Kharel Y, Brown AM, Bevan DR, Lynch KR, Santos WL (2017) Transforming sphingosine kinase 1 inhibitors into dual and sphingosine kinase 2 selective inhibitors: design, synthesis, and in vivo activity. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00233","journal-title":"J Med Chem"},{"key":"435_CR84","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-019-02377-7","author":"E Al-Barghouthy","year":"2019","unstructured":"Al-Barghouthy E, Abuhammad A, Taha MO (2019) QSAR-guided pharmacophore modeling and subsequent virtual screening identify novel TYK2 inhibitor. Med Chem Res. https:\/\/doi.org\/10.1007\/s00044-019-02377-7","journal-title":"Med Chem Res"},{"key":"435_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.06.019","author":"Y Xiang","year":"2010","unstructured":"Xiang Y, Hirth B, Kane JL, Liao J, Noson KD, Yee C et al (2010) Discovery of novel sphingosine kinase-1 inhibitors. Part 2. Bioorgan Med Chem Lett. https:\/\/doi.org\/10.1016\/j.bmcl.2010.06.019","journal-title":"Bioorgan Med Chem Lett"},{"key":"435_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.05.035","author":"W Qu","year":"2009","unstructured":"Qu W, Ploessl K, Truong H, Kung MP, Kung HF (2009) Iodophenyl tagged sphingosine derivatives: synthesis and preliminary biological evaluation. Bioorgan Med Chem Lett. https:\/\/doi.org\/10.1016\/j.bmcl.2009.05.035","journal-title":"Bioorgan Med Chem Lett"},{"key":"435_CR87","doi-asserted-by":"publisher","DOI":"10.1039\/c3md00201b","author":"HS Byun","year":"2013","unstructured":"Byun HS, Pyne S, MacRitchie N, Pyne NJ, Bittman R (2013) Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells. Medchemcomm. https:\/\/doi.org\/10.1039\/c3md00201b","journal-title":"Medchemcomm"},{"key":"435_CR88","doi-asserted-by":"publisher","DOI":"10.1021\/jm401399c","author":"DJ Baek","year":"2013","unstructured":"Baek DJ, MacRitchie N, Anthony NG, MacKay SP, Pyne S, Pyne NJ et al (2013) Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors. J Med Chem. https:\/\/doi.org\/10.1021\/jm401399c","journal-title":"J Med Chem"},{"key":"435_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.03.059","author":"H Ohno","year":"2017","unstructured":"Ohno H, Honda M, Hamada N, Miyagaki J, Iwata A, Otsuki K et al (2017) Identification of selective inhibitors of sphingosine kinases 1 and 2 through a structure\u2013activity relationship study of 4-epi-jaspine B. Bioorgan Med Chem. https:\/\/doi.org\/10.1016\/j.bmc.2017.03.059","journal-title":"Bioorgan Med Chem"},{"key":"435_CR90","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00070","author":"ME Schnute","year":"2017","unstructured":"Schnute ME, McReynolds MD, Carroll J, Chrencik J, Highkin MK, Iyanar K et al (2017) Discovery of a potent and selective sphingosine kinase 1 inhibitor through the molecular combination of chemotype-distinct screening hits. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00070","journal-title":"J Med Chem"},{"key":"435_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.06.030","author":"DJ Gustin","year":"2013","unstructured":"Gustin DJ, Li Y, Brown ML, Min X, Schmitt MJ, Wanska M et al (2013) Structure guided design of a series of sphingosine kinase (SphK) inhibitors. Bioorgan Med Chem Lett. https:\/\/doi.org\/10.1016\/j.bmcl.2013.06.030","journal-title":"Bioorgan Med Chem Lett"},{"key":"435_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.09.022","author":"Y Xiang","year":"2009","unstructured":"Xiang Y, Asmussen G, Booker M, Hirth B, Kane JL, Liao J et al (2009) Discovery of novel sphingosine kinase 1 inhibitors. Bioorgan Med Chem Lett. https:\/\/doi.org\/10.1016\/j.bmcl.2009.09.022","journal-title":"Bioorgan Med Chem Lett"},{"key":"435_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2015.10.004","author":"MA Al-Sha\u2019er","year":"2015","unstructured":"Al-Sha\u2019er MA, Mansi I, Almazari I, Hakooz N (2015) Evaluation of novel Akt1 inhibitors as anticancer agents using virtual co-crystallized pharmacophore generation. J Mol Gr Model. https:\/\/doi.org\/10.1016\/j.jmgm.2015.10.004","journal-title":"J Mol Gr Model"},{"key":"435_CR94","doi-asserted-by":"publisher","DOI":"10.1021\/ci6004299","author":"SN Rao","year":"2007","unstructured":"Rao SN, Head MS, Kulkarni A, LaLonde JM (2007) Validation studies of the site-directed docking program LibDock. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci6004299","journal-title":"J Chem Inf Model"},{"key":"435_CR95","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T","volume":"43","author":"DJ Diller","year":"2001","unstructured":"Diller DJ, Merz KM (2001) High throughput docking for library design and library prioritization. Proteins Struct Funct Genet 43:113\u2013124","journal-title":"Proteins Struct Funct Genet"},{"key":"435_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23768-7","author":"S Alam","year":"2018","unstructured":"Alam S, Khan F (2018) Virtual screening, docking, ADMET and system pharmacology studies on garcinia caged xanthone derivatives for anticancer activity. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-018-23768-7","journal-title":"Sci Rep"},{"key":"435_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/S1093-3263(02)00164-X","author":"CM Venkatachalam","year":"2003","unstructured":"Venkatachalam CM, Jiang X, Oldfield T, Waldman M (2003) LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Gr Model. https:\/\/doi.org\/10.1016\/S1093-3263(02)00164-X","journal-title":"J Mol Gr Model"},{"key":"435_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.10306","author":"G Wu","year":"2003","unstructured":"Wu G, Robertson DH, Brooks CL, Vieth M (2003) Detailed analysis of grid-based molecular docking: a case study of CDOCKER\u2014a CHARMm-based MD docking algorithm. J Comput Chem. https:\/\/doi.org\/10.1002\/jcc.10306","journal-title":"J Comput Chem"},{"key":"435_CR99","doi-asserted-by":"publisher","DOI":"10.2174\/138920306778559395","author":"A Jain","year":"2006","unstructured":"Jain A (2006) Scoring functions for protein-ligand docking. Curr Protein Pept Sci. https:\/\/doi.org\/10.2174\/138920306778559395","journal-title":"Curr Protein Pept Sci"},{"key":"435_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/1074-5521(95)90050-0","author":"DK Gehlhaar","year":"1995","unstructured":"Gehlhaar DK, Verkhivker GM, Rejto PA, Sherman CJ, Fogel DR, Fogel LJ et al (1995) Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. Chem Biol. https:\/\/doi.org\/10.1016\/1074-5521(95)90050-0","journal-title":"Chem Biol"},{"key":"435_CR101","doi-asserted-by":"publisher","DOI":"10.1021\/jm980536j","author":"I Muegge","year":"1999","unstructured":"Muegge I, Martin YC (1999) A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J Med Chem. https:\/\/doi.org\/10.1021\/jm980536j","journal-title":"J Med Chem"},{"key":"435_CR102","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/1521-3765(20020503)8:9<1976::AID-CHEM1976>3.0.CO;2-K","volume":"8","author":"I Muegge","year":"2002","unstructured":"Muegge I (2002) Pharmacophore features of potential drugs. Chem Eur J 8:1976\u20131981","journal-title":"Chem Eur J"},{"key":"435_CR103","doi-asserted-by":"publisher","DOI":"10.1021\/ci900450m","author":"J Hussain","year":"2010","unstructured":"Hussain J, Rea C (2010) Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets. J Chem Inf Model. https:\/\/doi.org\/10.1021\/ci900450m","journal-title":"J Chem Inf Model"},{"key":"435_CR104","doi-asserted-by":"publisher","DOI":"10.2174\/1381612824666180607124038","author":"KA Carpenter","year":"2018","unstructured":"Carpenter KA, Huang X (2018) Machine learning-based virtual screening and its applications to Alzheimer\u2019s drug discovery: a review. Curr Pharm Des. https:\/\/doi.org\/10.2174\/1381612824666180607124038","journal-title":"Curr Pharm Des"},{"key":"435_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.10.012","author":"A Lavecchia","year":"2015","unstructured":"Lavecchia A (2015) Machine-learning approaches in drug discovery: methods and applications. Drug Discov. https:\/\/doi.org\/10.1016\/j.drudis.2014.10.012","journal-title":"Drug Discov"},{"key":"435_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2016.12.008","author":"G Cano","year":"2017","unstructured":"Cano G, Garcia-Rodriguez J, Garcia-Garcia A, Perez-Sanchez H, Benediktsson JA, Thapa A et al (2017) Automatic selection of molecular descriptors using random forest: application to drug discovery. Expert Syst Appl. https:\/\/doi.org\/10.1016\/j.eswa.2016.12.008","journal-title":"Expert Syst Appl"},{"key":"435_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0024-5","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G et al (2019) Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. https:\/\/doi.org\/10.1038\/s41573-019-0024-5","journal-title":"Nat Rev Drug Discov"},{"key":"435_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s00500-020-05297-6","author":"I Wickramasinghe","year":"2020","unstructured":"Wickramasinghe I, Kalutarage H (2020) Naive Bayes: applications, variations and vulnerabilities: a review of literature with code snippets for implementation. Soft Comput. https:\/\/doi.org\/10.1007\/s00500-020-05297-6","journal-title":"Soft Comput"},{"key":"435_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2017.10.021","author":"H Zhang","year":"2017","unstructured":"Zhang H, Yu P, Ren JX, Li XB, Wang HL, Ding L et al (2017) Development of novel prediction model for drug-induced mitochondrial toxicity by using na\u00efve Bayes classifier method. Food Chem Toxicol. https:\/\/doi.org\/10.1016\/j.fct.2017.10.021","journal-title":"Food Chem Toxicol"},{"key":"435_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2020.104812","author":"H Zhang","year":"2020","unstructured":"Zhang H, Liu CT, Mao J, Shen C, Xie RL, Mu B (2020) Development of novel in silico prediction model for drug-induced ototoxicity by using na\u00efve Bayes classifier approach. Toxicol Vitr. https:\/\/doi.org\/10.1016\/j.tiv.2020.104812","journal-title":"Toxicol Vitr"},{"key":"435_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200600166","author":"S Derksen","year":"2006","unstructured":"Derksen S, Rau O, Schneider P, Schubert-Zsilavecz M, Schneider G (2006) Virtual screening for PPAR modulators using a probabilistic neural network. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.200600166","journal-title":"ChemMedChem"},{"key":"435_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2009.11.014","author":"SL Wang","year":"2010","unstructured":"Wang SL, Li X, Zhang S, Gui J, Huang DS (2010) Tumor classification by combining PNN classifier ensemble with neighborhood rough set based gene reduction. Comput Biol Med. https:\/\/doi.org\/10.1016\/j.compbiomed.2009.11.014","journal-title":"Comput Biol Med"},{"key":"435_CR113","doi-asserted-by":"publisher","DOI":"10.11613\/bm.2012.031","author":"ML McHugh","year":"2012","unstructured":"McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med. https:\/\/doi.org\/10.11613\/bm.2012.031","journal-title":"Biochem Med"},{"key":"435_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.08.023","author":"MM Hatmal","year":"2021","unstructured":"Hatmal MM, Abuyaman O, Taha MO (2021) Docking-generated multiple ligand poses for bootstrapping bioactivity classifying machine learning: repurposing covalent inhibitors for COVID-19-related TMPRSS2 as case study. Comput Struct Biotechnol J. https:\/\/doi.org\/10.1016\/j.csbj.2021.08.023","journal-title":"Comput Struct Biotechnol J"},{"key":"435_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-007-9163-6","author":"J Kirchmair","year":"2008","unstructured":"Kirchmair J, Markt P, Distinto S, Wolber G, Langer T (2008) Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection\u2014what can we learn from earlier mistakes? J Comput Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-007-9163-6","journal-title":"J Comput Aided Mol Des"},{"key":"435_CR116","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-014-9740-4","author":"MO Taha","year":"2014","unstructured":"Taha MO, Habash M, Khanfar MA (2014) The use of docking-based comparative intermolecular contacts analysis to identify optimal docking conditions within glucokinase and to discover of new GK activators. J Comput-Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-014-9740-4","journal-title":"J Comput-Aided Mol Des"},{"key":"435_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/jm049092j","volume":"1","author":"N Triballeau","year":"2005","unstructured":"Triballeau N, Acher F, Brabet I, Pin JP, Bertrand HO (2005) Virtual screening workflow development guided by the \u201creceiver operating characteristic\u201d curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 1:1. https:\/\/doi.org\/10.1021\/jm049092j","journal-title":"J Med Chem"},{"key":"435_CR118","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819001481","author":"PK Kondeti","year":"2019","unstructured":"Kondeti PK, Ravi K, Mutheneni SR, Kadiri MR, Kumaraswamy S, Vadlamani R et al (2019) Applications of machine learning techniques to predict filariasis using socio-economic factors. Epidemiol Infect. https:\/\/doi.org\/10.1017\/S0950268819001481","journal-title":"Epidemiol Infect"},{"key":"435_CR119","doi-asserted-by":"publisher","DOI":"10.1007\/s11222-016-9696-4","author":"A Vehtari","year":"2017","unstructured":"Vehtari A, Gelman A, Gabry J (2017) Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC. Stat Comput. https:\/\/doi.org\/10.1007\/s11222-016-9696-4","journal-title":"Stat Comput"},{"key":"435_CR120","doi-asserted-by":"publisher","DOI":"10.1021\/ci00020a020","author":"D Rogers","year":"1994","unstructured":"Rogers D, Hopfinger AJ (1994) Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. J Chem Inf Comput Sci. https:\/\/doi.org\/10.1021\/ci00020a020","journal-title":"J Chem Inf Comput Sci"},{"key":"435_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.rse.2008.02.011","author":"JCW Chan","year":"2008","unstructured":"Chan JCW, Paelinckx D (2008) Evaluation of random forest and adaboost tree-based ensemble classification and spectral band selection for ecotope mapping using airborne hyperspectral imagery. Remote Sens Environ. https:\/\/doi.org\/10.1016\/j.rse.2008.02.011","journal-title":"Remote Sens Environ"},{"key":"435_CR122","doi-asserted-by":"crossref","unstructured":"James G, Witten D, Hastie T, Tibishirani R (2013) An introduction to statistical learning with applications in R (older version). Springer Texts in Statistics.","DOI":"10.1007\/978-1-4614-7138-7"},{"key":"435_CR123","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2017-0061","author":"MM Hatmal","year":"2017","unstructured":"Hatmal MM, Taha MO (2017) Simulated annealing molecular dynamics and ligand-receptor contacts analysis for pharmacophore modeling. Future Med Chem. https:\/\/doi.org\/10.4155\/fmc-2017-0061","journal-title":"Future Med Chem"},{"key":"435_CR124","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-016-9984-2","author":"MM Hatmal","year":"2016","unstructured":"Hatmal MM, Jaber S, Taha MO (2016) Combining molecular dynamics simulation and ligand-receptor contacts analysis as a new approach for pharmacophore modeling: beta-secretase 1 and check point kinase 1 as case studies. J Comput Aided Mol Des. https:\/\/doi.org\/10.1007\/s10822-016-9984-2","journal-title":"J Comput Aided Mol Des"},{"key":"435_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25246003","author":"MS Hijjawi","year":"2020","unstructured":"Hijjawi MS, Abutayeh RF, Taha MO (2020) Structure-based discovery and bioactivity evaluation of novel aurora-A kinase inhibitors as anticancer agents via docking-based comparative intermolecular contacts analysis (dbCICA). Molecules. https:\/\/doi.org\/10.3390\/molecules25246003","journal-title":"Molecules"},{"key":"435_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2018.03.020","author":"AH Al-Nadaf","year":"2018","unstructured":"Al-Nadaf AH, Salah SA, Taha MO (2018) Discovery of new Gyrase \u03b2 inhibitors via structure based modeling. Comput Biol Chem. https:\/\/doi.org\/10.1016\/j.compbiolchem.2018.03.020","journal-title":"Comput Biol Chem"},{"key":"435_CR127","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-017-1976-9","author":"M Habash","year":"2017","unstructured":"Habash M, Abuhamdah S, Younis K, Taha MO (2017) Docking-based comparative intermolecular contacts analysis and in silico screening reveal new potent acetylcholinesterase inhibitors. Med Chem Res. https:\/\/doi.org\/10.1007\/s00044-017-1976-9","journal-title":"Med Chem Res"},{"key":"435_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.10.071","author":"R Shahin","year":"2012","unstructured":"Shahin R, Taha MO (2012) Elaborate ligand-based modeling and subsequent synthetic exploration unveil new nanomolar Ca2+\/calmodulin-dependent protein kinase II inhibitory leads. Bioorgan Med Chem. https:\/\/doi.org\/10.1016\/j.bmc.2011.10.071","journal-title":"Bioorgan Med Chem"},{"key":"435_CR129","doi-asserted-by":"publisher","DOI":"10.1177\/1087057106296047","author":"MA Kashem","year":"2007","unstructured":"Kashem MA, Nelson RM, Yingling JD, Pullen SS, Prokopowicz AS, Jones JW et al (2007) Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors. J Biomol Screen. https:\/\/doi.org\/10.1177\/1087057106296047","journal-title":"J Biomol Screen"},{"key":"435_CR130","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0587.2012.07348.x","author":"CF Dormann","year":"2013","unstructured":"Dormann CF, Elith J, Bacher S, Buchmann C, Carl G, Carr\u00e9 G et al (2013) Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography. https:\/\/doi.org\/10.1111\/j.1600-0587.2012.07348.x","journal-title":"Ecography"},{"key":"435_CR131","doi-asserted-by":"publisher","DOI":"10.1039\/b110779h","author":"M Meloun","year":"2002","unstructured":"Meloun M, Militk\u00fd J, Hill M, Brereton RG (2002) Crucial problems in regression modelling and their solutions. Analyst. https:\/\/doi.org\/10.1039\/b110779h","journal-title":"Analyst"},{"key":"435_CR132","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20111929","author":"ME Schnute","year":"2012","unstructured":"Schnute ME, McReynolds MD, Kasten T, Yates M, Jerome G, Rains JW et al (2012) Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Biochem J. https:\/\/doi.org\/10.1042\/BJ20111929","journal-title":"Biochem J"},{"key":"435_CR133","doi-asserted-by":"publisher","DOI":"10.1021\/jm061103g","author":"B Shoichet","year":"2006","unstructured":"Shoichet B (2006) Interpreting steep dose-response curves in early inhibitor discovery. J Med Chem. https:\/\/doi.org\/10.1021\/jm061103g","journal-title":"J Med Chem"},{"key":"435_CR134","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2019-0198","author":"S Siddamurthi","year":"2020","unstructured":"Siddamurthi S, Gutti G, Jana S, Kumar A, Singh SK (2020) Anthraquinone: a promising scaffold for the discovery and development of therapeutic agents in cancer therapy. Future Med Chem. https:\/\/doi.org\/10.4155\/fmc-2019-0198","journal-title":"Future Med Chem"},{"key":"435_CR135","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.169062","author":"M Stasevych","year":"2015","unstructured":"Stasevych M, Zvarych V, Lunin V, Halenova T, Savchuk O, Dudchak O et al (2015) Novel anthraquinone-based derivatives as potent inhibitors for receptor tyrosine kinases. Indian J Pharm Sci. https:\/\/doi.org\/10.4103\/0250-474X.169062","journal-title":"Indian J Pharm Sci"},{"key":"435_CR136","doi-asserted-by":"publisher","DOI":"10.1021\/ml4000047","author":"Z Liang","year":"2013","unstructured":"Liang Z, Ai J, Ding X, Peng X, Zhang D, Zhang R et al (2013) Anthraquinone derivatives as potent inhibitors of c-Met kinase and the extracellular signaling pathway. ACS Med Chem Lett. https:\/\/doi.org\/10.1021\/ml4000047","journal-title":"ACS Med Chem Lett"},{"key":"435_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2614(82)80009-2","author":"AT Balaban","year":"1982","unstructured":"Balaban AT (1982) Highly discriminating distance-based topological index. Chem Phys Lett. https:\/\/doi.org\/10.1016\/0009-2614(82)80009-2","journal-title":"Chem Phys Lett"},{"key":"435_CR138","volume-title":"Molecular connectivity in chemistry and drug research","author":"M Keir","year":"1976","unstructured":"Keir M, Hall L (1976) Molecular connectivity in chemistry and drug research. Academic Press, New York"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-021-00435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-021-00435-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-021-00435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T03:11:17Z","timestamp":1644549077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-021-00435-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":138,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["435"],"URL":"https:\/\/doi.org\/10.1007\/s10822-021-00435-0","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}